Fluorokines™ For Chimeric Antigen Receptor Detection

R&D Systems™ Fluorokines are fluorescent-labeled proteins that simplify the detection of chimeric antigen receptors (CARs) following T cell or NK cell transduction. This is a critical step in the production of CAR-T or CAR-NK cells for cancer immunotherapy. Fluorokines are rigorously tested to ensure consistent labeling and activity.

Some advantages of Fluorokines for evaluating CAR expression include direct detection, of targeted molecules, reduced processing time, and compatibility with antibody panels.